New anticoagulants for the prevention of venous thromboembolism. - Wikidata - wikimedia - TriplyDB

New anticoagulants for the prevention of venous thromboembolism.

New anticoagulants for the prevention of venous thromboembolism.

http://www.wikidata.org/entity/Q37763535

about

Managing anticoagulation for atrial fibrillation: current issues and future strategies Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.New options in anticoagulation for the prevention of venous thromboembolism and stroke.Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic disease.Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery.Direct thrombin and factor Xa inhibition for stroke prevention in patients with atrial fibrillation.Prevention and treatment of venous thromboembolism with new oral anticoagulants: a practical update for clinicians.Fluorogenic peptide-based substrates for monitoring thrombin activity.Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2).

P2860

Q26991728-E49CF3E3-95D7-4247-9B13-914140242751 Q34088870-A50B6B05-ECFF-4CE3-8A6C-35B724EB5EA8 Q34906214-E72F3F80-837B-4145-8879-06B30C231910 Q37871725-E43AF0A6-ABFD-434F-A4F8-F02C8B8822C5 Q37998912-73A53FB6-163D-429E-9E00-D77CFE84F42A Q38087189-D629076A-B929-4D1D-95F6-396E9360D4C1 Q41205933-C4475D3C-5662-402A-B07F-C1B870250BF7 Q44526274-9FEDE656-806A-4A34-9EC6-1AAFD597C265 Q45040087-0294E76B-569A-495A-928E-7A1340B28047

P2860

New anticoagulants for the prevention of venous thromboembolism.

http://www.wikidata.org/entity/Q37763535

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 May 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New anticoagulants for the prevention of venous thromboembolism.

@en

New anticoagulants for the prevention of venous thromboembolism.

@nl

type

label

New anticoagulants for the prevention of venous thromboembolism.

@en

New anticoagulants for the prevention of venous thromboembolism.

@nl

prefLabel

New anticoagulants for the prevention of venous thromboembolism.

@en

New anticoagulants for the prevention of venous thromboembolism.

@nl

P1433

Q37763535-1AC4AE4B-6D98-4E58-B6CF-585990EF0368

P1476

Q37763535-FD80726E-5EFB-4FB4-B70C-5E50D35E8644

P2093

Q37763535-47BE782C-8707-47CE-A41D-4655749031DB

Q37763535-6011CB88-B987-489B-A8F2-D6AED026B4BB

Q37763535-AEB13219-36E5-48F1-B320-D652CDB0268A

P2860

Q37763535-0A499849-6C0E-45B1-9B7F-11E66CE1F6A1

Q37763535-0BD46895-B7EA-4A1D-A801-7B727B22E41C

Q37763535-122112C1-3B34-45DC-8561-983416EDAD41

Q37763535-146E6C8C-FD84-4AE4-9C13-64C9A27716AF

Q37763535-1AD9B4B0-7470-414A-8C83-431E0A699710

Q37763535-2B48570A-9859-4059-90FF-E30ADAD44B0B

Q37763535-2D11EFD3-6474-47FB-AB57-196BC44A0B98

Q37763535-2D342519-9D3E-45A5-84B7-A631DFFDA976

Q37763535-2D734E62-18C8-4169-AA52-61981311F76C

Q37763535-4423CC07-F337-4B8F-83B9-DC3F11343A1B

P304

Q37763535-1A6418CC-168A-417A-81F5-104D946F99C6

P31

Q37763535-6DF5D095-2DB0-41AC-8C43-5328A890B3BD

Q37763535-B9C3C1AB-9AF3-44DE-99A1-EAE24B6A36A2

P356

Q37763535-5C7A6723-8615-4714-B361-A86D67DC0ABC

P407

Q37763535-C761D820-3E6C-4C74-8015-1ABAE04F0259

P478

Q37763535-752826CE-48E8-43BD-B829-703DCC149500

P577

Q37763535-B625F7BC-0A78-434D-9289-A972DBCC204C

P5875

Q37763535-66E2365D-0BB3-4937-B5CF-A5561C3AFB25

P698

Q37763535-6389DEEC-D65D-4D58-B9C7-497295DCC6A5

P921

Q37763535-C60933FF-9068-472C-8CEE-5799D6306618

Q37763535-DDABC797-FD0E-4205-B7C6-4B56ACB2E9F1

P932

Q37763535-2E1F70B9-DA25-42DB-841E-C3DAAFF0ABAD

P356

P1433

Drug Design, Development and Therapy

P1476

New anticoagulants for the prevention of venous thromboembolism.

@en

P2093

Alessandra Lignani

http://www.w3.org/2001/XMLSchema#string

Cecilia Becattini

http://www.w3.org/2001/XMLSchema#string

Giancarlo Agnelli

http://www.w3.org/2001/XMLSchema#string

P2860

New oral anticoagulants in atrial fibrillation

A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

The dynamics of thrombin formation

Apixaban metabolism and pharmacokinetics after oral administration to humans.

Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.

Apixaban or enoxaparin for thromboprophylaxis after knee replacement.

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.

Cancer and venous thromboembolism.

BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study.

P304

49-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S6074

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44657656

http://www.w3.org/2001/XMLSchema#string

P698

20531960

http://www.w3.org/2001/XMLSchema#string

P921

venous thromboembolism

anticoagulation

P932

2880336

http://www.w3.org/2001/XMLSchema#string